Radiotherapy in Malignant Myoepithelioma of the Soft Palate - Case Report.

Case Rep Oncol

Department of Oncology and Radiotherapy, Mendel Cancer Center, Nový Jicín, Czech Republic.

Published: July 2009

AI Article Synopsis

  • Myoepithelioma is a rare tumor, making up about 1% of salivary gland tumors.
  • There are no established treatment guidelines due to its rarity, and there is limited literature on the condition.
  • A case is presented where radiotherapy had a positive palliative effect on an elderly patient.

Article Abstract

Myoepithelioma is a very rare neoplasm that accounts only for about 1% of all salivary gland tumours. As the lesion is so rare, there are no specific recommendations or guidelines for its treatment. In the literature, there have been only a few cases reported without any existing data concerning radiotherapy. We present a very good palliative effect of radiotherapy in a very old man.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2918858PMC
http://dx.doi.org/10.1159/000228546DOI Listing

Publication Analysis

Top Keywords

radiotherapy malignant
4
malignant myoepithelioma
4
myoepithelioma soft
4
soft palate
4
palate case
4
case report
4
report myoepithelioma
4
myoepithelioma rare
4
rare neoplasm
4
neoplasm accounts
4

Similar Publications

To undertake a mixed-methodology implementation study to improve the well-being of men with gastrointestinal late effects following radical radiotherapy for prostate cancer. All men completed a validated screening tool for late bowel effects (ALERT-B) and the Gastrointestinal Symptom Rating Score (GSRS); men with a positive score on ALERT-B were offered management following a peer reviewed algorithm for pelvic radiation disease (PRD). Health-related quality of life (HRQoL) at baseline, 6 and 12 months; and healthcare resource usage (HRU) and patient, support-giver, staff experience and acceptability of staff training (qualitative analysis) were assessed.

View Article and Find Full Text PDF

Circulating tumor cells (CTCs) are tumor cells that detach from the primary tumor site and enter the bloodstream. They hold significant value for the early detection, diagnosis, and treatment of tumors. CTC detection methods can be classified into in vivo and in vitro techniques.

View Article and Find Full Text PDF

Rare malignant ovarian tumors: a review.

Jpn J Clin Oncol

January 2025

Department of Gynecology, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045, Japan.

There are many histologic types of gynecologic malignancies. I reviewed three rare ovarian tumor types that have poor prognoses. Ovarian mesonephric-like adenocarcinoma (MLA) is a newly described histological type known for its aggressive behavior.

View Article and Find Full Text PDF

Background: This study aimed to develop an automated algorithm to noninvasively distinguish gliomas from other intracranial pathologies, preventing misdiagnosis and ensuring accurate analysis before further glioma assessment.

Methods: A cohort of 1280 patients with a variety of intracranial pathologies was included. It comprised 218 gliomas (mean age 54.

View Article and Find Full Text PDF

The characteristics of the tumor immune microenvironment in colorectal cancer with different MSI status and current therapeutic strategies.

Front Immunol

January 2025

Department of Targeting Therapy and Immunology, Cancer Center, West China Hospital, Sichuan University, Chengdu, Sichuan, China.

Colorectal cancer (CRC) remains a significant cause of cancer-related mortality worldwide. Despite advancements in surgery, chemotherapy, and radiotherapy, the effectiveness of these conventional treatments is limited, particularly in advanced cases. Therefore, transition to novel treatment is urgently needed.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!